Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus–coinfected liver transplant recipients

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|2|272-274

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.2, 2015-02, pp. : 272-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 823-830

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 228-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus–coinfected patients with mild fibrosis in the short term

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1503-1511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 794-796

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2442-2447

John Wiley & Sons Inc

Access to resources Recommend Favorite